/maggie

About maggie

This author has not yet filled in any details.
So far maggie has created 59 blog entries.

The USFDA has reviewed and commented on the results of the phase 1 clinical trial of NBM-BMX and suggested changes on the draft clinical protocol of the phase 2 program

In 2018, in a letter approving the initiation of phase 1 clinical trials, the USFDA requested NatureWise schedule an end of phase 1 (EOP1) meeting with the FDA when NatureWise completed the phase 1 clinical program. In September 2021, NatureWise completed a phase 1 clinical trial in the USA, submitted the trial results to the USFDA along with a draft of the phase 2 study protocol for glioblastoma multiforme, and requested an EOP1 meeting. In December 2021, in the response letter for the EOP1 meeting, the USFDA commented on the trial results and suggested changes for the phase 2 clinical study [...]

2022-01-06T15:29:18+00:00 2022 / 01 / 06|Categories: News|

NBM-BMX RECEIVED US FDA APPROVAL TO PROCEED PHASE I CLINICAL TRIAL

NatureWise’s new chemical entity, NBM-MBX, received US Food and Drug Administration (FDA) approval on July 24th to proceed Phase I clinical trial. NBM-MBX is an isoform-selective histone deacetylase 8 (HDAC 8) inhibitor. The high specificity produces less side effects than those of non-selective HDAC inhibitors. […]

2019-07-15T15:18:47+00:00 2018 / 07 / 26|Categories: News|

LipoCol Forte® Research Paper

2005_Eur J Endocrinol_Efficacy and safety of Monascus 2007_Eur J Cardiovasc Prev Rehabil_Efficacy of Monascus purpureus Went rice 2012_Interaction between Red Yeast Rice and CYP450 Enzymes 2013_Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice Download Download Download Download

2018-08-16T17:28:01+00:00 2012 / 12 / 01|Categories: 彥臣相關活動|
error: Content is protected !!